Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000899140-25-001321·DISBROW ROBERT
Schedule 13G ownership disclosure
EUPRAXIA PHARMACEUTICALS INC
Common Shares, with no par value · CUSIP: 29842P105
Event date: 2025-09-30
- Filing-level shares
- 3,568,150
- Percent of class
- 7%
- Robert Disbrow
Shares: 3,568,150 · Class: 7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-25-001321
- Form type
- SCHEDULE 13G/A
- Filer
- DISBROW ROBERT
- CIK
- CIK 1515937
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership